Moderna

Moderna mRNA vaccine almost halves the risk of skin cancer returning

Here’s what the new Merck-Moderna mRNA cancer vaccine data actually show

Moderna has a plan to revolutionize how certain cancers are treated. We’re about to find out its potential in melanoma.

The Moderna cancer vaccine offers hope — now we must speed up personalized therapies

Moderna’s Shift to Cancer Company Lifts Stock Up 177%

Moderna cancer vaccine stops melanoma returning: what’s next for personalized treatments?

Moderna and Merck announce ‘landmark’ trial showing mRNA therapy significantly cuts odds of recurrent skin cancer

Moderna, Merck Say mRNA Vaccine Prevents Melanoma From Returning

U.S. approves Moderna’s mRNA vaccine for flu—the first of its kind

F.D.A. Approves Moderna’s mRNA Flu Vaccine

Scientists identify new spinosaurid, Moderna flu shot back on track, universal inhaled vaccine shows promise

F.D.A. Reverses Decision and Agrees to Review Moderna’s Flu Vaccine

FDA reverses course, will review Moderna's mRNA flu vaccine

FDA agrees to review Moderna mRNA flu vaccine in dramatic reversal

U.S. Health Officials Defend Rejection of Moderna’s Flu Vaccine

Moderna's CEO said the company doesn't plan to invest in new late-stage vaccine trials due to growing opposition to immunizations from US officials

Moderna curbing investments in vaccine trials due to US backlash, CEO tells Bloomberg TV

Moderna CEO Responds to RFK Jr.’s Crusade Against the Covid-19 Vaccine

FDA approves Moderna's new COVID-19 vaccine

U.S. Cancels Contract With Moderna to Develop Bird Flu Vaccine